-
TSBX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Turnstone Biologics (TSBX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 24.25 mm | 24.25 mm | 24.25 mm | 24.25 mm | 24.25 mm | 24.25 mm |
Cash burn (monthly) | (no burn) | 1.22 mm | 6.12 mm | 6.58 mm | (no burn) | 1.32 mm |
Cash used (since last report) | n/a | 6.48 mm | 32.52 mm | 34.96 mm | n/a | 6.99 mm |
Cash remaining | n/a | 17.77 mm | -8.28 mm | -10.71 mm | n/a | 17.26 mm |
Runway (months of cash) | n/a | 14.6 | -1.4 | -1.6 | n/a | 13.1 |
13F holders | Current |
---|---|
Total holders | 24 |
Opened positions | 3 |
Closed positions | 25 |
Increased positions | 5 |
Reduced positions | 9 |
13F shares | Current |
---|---|
Total value | 5.57 bn |
Total shares | 13.45 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Orbimed Advisors | 3.10 mm | $1.73 bn |
Versant Venture Capital V | 2.90 mm | $33.05 mm |
FMR | 1.17 mm | $653.47 mm |
Partner Fund Management | 932.35 k | $519.41 mm |
Point72 Asset Management | 932.23 k | $519.34 mm |
BAC Bank of America | 911.74 k | $507.84 mm |
Citadel Advisors | 689.21 k | $383.96 mm |
Vanguard | 579.00 k | $322.50 mm |
72 Investment | 549.98 k | $306.39 mm |
Sectoral Asset Management | 517.65 k | $288.38 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jun 24 | Gould Robert J | Stock Option Common Stock | Grant | Acquire A | No | No | 2.69 | 12,770 | 34.35 k | 12,770 |
3 Jun 24 | Davis Jerel | Stock Option Common Stock | Grant | Acquire A | No | No | 2.69 | 12,770 | 34.35 k | 12,770 |
3 Jun 24 | Kanya Rajangam | Stock Option Common Stock | Grant | Acquire A | No | No | 2.69 | 12,770 | 34.35 k | 12,770 |
3 Jun 24 | Waddill William D. | Stock Option Common Stock | Grant | Acquire A | No | No | 2.69 | 12,770 | 34.35 k | 12,770 |
3 Jun 24 | Rishi Gupta | Stock Option Common Stock | Grant | Acquire A | No | No | 2.69 | 12,770 | 34.35 k | 12,770 |